Canada markets open in 9 hours 25 minutes

Champions Oncology, Inc. (CSBR)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
5.00000.0000 (0.00%)
At close: 04:00PM EDT

Champions Oncology, Inc.

One University Plaza
Suite 307
Hackensack, NJ 07601
United States
201 808 8400
https://www.championsoncology.com

Sector(s): Healthcare
Industry: Biotechnology
Full Time Employees: 230

Key Executives

NameTitlePayExercisedYear Born
Dr. Ronnie Morris M.D.CEO & Director600kN/A1966
Mr. David Barry Miller M.B.A.Chief Financial Officer285kN/A1969
Mr. Brady DavisPresidentN/AN/AN/A
Dr. Maria Mancini Ph.D.Chief Operating OfficerN/AN/AN/A
Mr. Arthur HansonVice President of TechnologyN/AN/AN/A
Ms. Rachel A. Bunting M.B.A., M.S., MBA, MSVP of Global MarketingN/AN/AN/A
Mr. David DeOrnellis BS, CMAR, CPIA, RLATGExecutive Vice President of Global Laboratory OperationsN/AN/AN/A
Dr. Michael Ritchie M.B.A., Ph.D.Chief Commercial OfficerN/AN/AN/A
Dr. Karin Abarca Heidemann Ph.D.Executive Vice President of Global Scientific OperationsN/AN/AN/A
Dr. Marianna Zipeto Ph.D.Executive Vice President of Commercial, Research Services & PartneringN/AN/AN/A
Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Champions Oncology, Inc., a technology-enabled research company, provides transformative technology solutions for drug discovery and development in the United States. The company, through its Tumorgraft Technology Platform, provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice. It also offers Translational Oncology Solutions that utilizes its technology platform to assist pharmaceutical and biotechnology companies with their drug development process. In addition, it offers Lumin Bioinformatics, a dynamic analytic and visualization software that empowers cancer biologists to harness the power of computational science in a convenient and sophisticated tool. The company markets its products through internet, word of mouth, and sales force to patients and physicians. Champions Oncology, Inc. was formerly known as Champions Biotechnology, Inc. and changed its name to Champions Oncology, Inc. in April 2011. The company was incorporated in 1985 and is headquartered in Hackensack, New Jersey.

Corporate Governance

Champions Oncology, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.